AMAG Pharmaceuticals, Inc. Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2011

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the second quarter ended June 30, 2011.

MORE ON THIS TOPIC